These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35060248)

  • 21. Coronary Microvascular Dysfunction in Patients With Heart Failure: Characterization of Patterns in HFrEF Versus HFpEF.
    Paolisso P; Gallinoro E; Belmonte M; Bertolone DT; Bermpeis K; De Colle C; Shumkova M; Leone A; Caglioni S; Esposito G; Fabbricatore D; Moya A; Delrue L; Penicka M; De Bruyne B; Barbato E; Bartunek J; Vanderheyden M
    Circ Heart Fail; 2024 Jan; 17(1):e010805. PubMed ID: 38108151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of coronary microvascular dysfunction in heart failure with preserved ejection fraction.
    Tona F; Montisci R; Iop L; Civieri G
    Rev Cardiovasc Med; 2021 Mar; 22(1):97-104. PubMed ID: 33792251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelial-cell-mediated mechanism of coronary microvascular dysfunction leading to heart failure with preserved ejection fraction.
    Wang Y; Zhang J; Wang Z; Wang C; Ma D
    Heart Fail Rev; 2023 Jan; 28(1):169-178. PubMed ID: 35266091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generalizability of HFA-PEFF and H
    Faxen UL; Venkateshvaran A; Shah SJ; Lam CSP; Svedlund S; Saraste A; Beussink-Nelson L; Lagerstrom Fermer M; Gan LM; Hage C; Lund LH
    J Card Fail; 2021 Jul; 27(7):756-765. PubMed ID: 33647474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of coronary microvascular dysfunction and cardiac bridge integrator 1, a cardiomyocyte dysfunction biomarker.
    Pacheco C; Wei J; Shufelt C; C Hitzeman T; Cook-Wiens G; Pepine CJ; Handberg E; Anderson RD; Petersen J; Hong T; M Shaw R; Bairey Merz CN
    Clin Cardiol; 2021 Nov; 44(11):1586-1593. PubMed ID: 34528718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sex Differences in Heart Failure With Preserved Ejection Fraction.
    Sotomi Y; Hikoso S; Nakatani D; Mizuno H; Okada K; Dohi T; Kitamura T; Sunaga A; Kida H; Oeun B; Sato T; Komukai S; Tamaki S; Yano M; Hayashi T; Nakagawa A; Nakagawa Y; Yasumura Y; Yamada T; Sakata Y;
    J Am Heart Assoc; 2021 Feb; 10(5):e018574. PubMed ID: 33619973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prognostic value of highly sensitive cardiac troponin assays for adverse events in men and women with stable heart failure and a preserved vs. reduced ejection fraction.
    Gohar A; Chong JPC; Liew OW; den Ruijter H; de Kleijn DPV; Sim D; Yeo DPS; Ong HY; Jaufeerally F; Leong GKT; Ling LH; Lam CSP; Richards AM
    Eur J Heart Fail; 2017 Dec; 19(12):1638-1647. PubMed ID: 28849609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microvascular endothelial dysfunction in skin is associated with higher risk of heart failure with preserved ejection fraction in women with type 2 diabetes: the Hoorn Diabetes Care System Cohort.
    Canto ED; van Deursen L; Hoek AG; Elders PJM; den Ruijter HM; van der Velden J; van Empel V; Serné EH; Eringa EC; Beulens JWJ
    Cardiovasc Diabetol; 2023 Sep; 22(1):234. PubMed ID: 37658327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction.
    Taqueti VR; Solomon SD; Shah AM; Desai AS; Groarke JD; Osborne MT; Hainer J; Bibbo CF; Dorbala S; Blankstein R; Di Carli MF
    Eur Heart J; 2018 Mar; 39(10):840-849. PubMed ID: 29293969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Body Composition, Coronary Microvascular Dysfunction, and Future Risk of Cardiovascular Events Including Heart Failure.
    Souza ACDAH; Rosenthal MH; Moura FA; Divakaran S; Osborne MT; Hainer J; Dorbala S; Blankstein R; Di Carli MF; Taqueti VR
    JACC Cardiovasc Imaging; 2024 Feb; 17(2):179-191. PubMed ID: 37768241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired systolic function by strain imaging in heart failure with preserved ejection fraction.
    Kraigher-Krainer E; Shah AM; Gupta DK; Santos A; Claggett B; Pieske B; Zile MR; Voors AA; Lefkowitz MP; Packer M; McMurray JJ; Solomon SD;
    J Am Coll Cardiol; 2014 Feb; 63(5):447-56. PubMed ID: 24184245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteomic Associations of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) in Heart Failure With Preserved Ejection Fraction.
    Azzo JD; Dib MJ; Zagkos L; Zhao L; Wang Z; Chang CP; Ebert C; Salman O; Gan S; Zamani P; Cohen JB; van Empel V; Richards AM; Javaheri A; Mann DL; Rietzschel ER; Schafer PH; Seiffert DA; Gill D; Burgess S; Ramirez-Valle F; Gordon DA; Cappola TP; Chirinos JA
    Circ Heart Fail; 2024 Feb; 17(2):e011146. PubMed ID: 38299345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma proteomic analysis of association between atrial fibrillation, coronary microvascular disease and heart failure.
    Dixit G; Blair J; Ozcan C
    Am J Cardiovasc Dis; 2022; 12(2):81-91. PubMed ID: 35600285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteomic Correlates of the Urinary Protein/Creatinine Ratio in Heart Failure With Preserved Ejection Fraction.
    Gan S; Zhao L; Salman O; Wang Z; Ebert C; Azzo JD; Dib MJ; Zamani P; Cohen JB; Kammerhoff K; Schafer P; Seiffert DA; Ramirez-Valle F; Gordon DA; Cvijic ME; Gunawardhana K; Liu L; Chang CP; Cappola TP; Chirinos JA
    Am J Cardiol; 2023 Nov; 206():312-319. PubMed ID: 37734292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and Prognostic Significance of Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction.
    Arnold JR; Kanagala P; Budgeon CA; Jerosch-Herold M; Gulsin GS; Singh A; Khan JN; Chan DCS; Squire IB; Ng LL; McCann GP
    JACC Cardiovasc Imaging; 2022 Jun; 15(6):1001-1011. PubMed ID: 35033490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship Between Focal and Diffuse Fibrosis Assessed by CMR and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction.
    Kanagala P; Cheng ASH; Singh A; Khan JN; Gulsin GS; Patel P; Gupta P; Arnold JR; Squire IB; Ng LL; McCann GP
    JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2291-2301. PubMed ID: 30772227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coronary Microvascular Dysfunction and Heart Failure with Preserved Ejection Fraction - implications for Chronic Inflammatory Mechanisms.
    Fopiano KA; Jalnapurkar S; Davila AC; Arora V; Bagi Z
    Curr Cardiol Rev; 2022; 18(2):e310821195986. PubMed ID: 34488616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and correlates of left ventricular diastolic dysfunction and heart failure with preserved ejection fraction in elderly community residents.
    Cui X; Zhou J; Jin X; Zhou J; Fu M; Hu K; Sun A; Ge J
    Int J Cardiol; 2017 Jan; 227():820-825. PubMed ID: 27836303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arterial stiffness assessment in coronary microvascular dysfunction and heart failure with preserved ejection fraction: An initial report from the WISE-CVD continuation study.
    Rezaeian P; Shufelt CL; Wei J; Pacheco C; Cook-Wiens G; Berman D; Tamarappoo B; Thomson LE; Nelson MD; Anderson RD; Petersen J; Handberg EM; Pepine CJ; Merz CNB
    Am Heart J Plus; 2024 May; 41():100390. PubMed ID: 38600957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction.
    Mohammed SF; Hussain S; Mirzoyev SA; Edwards WD; Maleszewski JJ; Redfield MM
    Circulation; 2015 Feb; 131(6):550-9. PubMed ID: 25552356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.